SPINAL AND BULBAR MUSCULAR ATROPHY
Clinical trials for SPINAL AND BULBAR MUSCULAR ATROPHY explained in plain language.
Never miss a new study
Get alerted when new SPINAL AND BULBAR MUSCULAR ATROPHY trials appear
Sign up with your email to follow new studies for SPINAL AND BULBAR MUSCULAR ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
1905 SBMA patients monitored for up to 8 years on leuprorelin
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug leuprorelin in 1,905 people with spinal and bulbar muscular atrophy (SBMA), a rare muscle-weakening disease. Participants were followed for up to 8 years in routine medical care. The main goals were to track …
Matched conditions: SPINAL AND BULBAR MUSCULAR ATROPHY
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug shows promise for rare Muscle-Wasting disease
Disease control CompletedThis study tested an experimental drug called NIDO-361 in 54 men with spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease. The goal was to see if the drug is safe and can help maintain or improve muscle mass. Participants received either the drug or a place…
Matched conditions: SPINAL AND BULBAR MUSCULAR ATROPHY
Phase: PHASE2 • Sponsor: Nido Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC